1. Home
  2. PODD vs IP Comparison

PODD vs IP Comparison

Compare PODD & IP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • IP
  • Stock Information
  • Founded
  • PODD 2000
  • IP 1898
  • Country
  • PODD United States
  • IP United States
  • Employees
  • PODD N/A
  • IP N/A
  • Industry
  • PODD Medical/Dental Instruments
  • IP Paper
  • Sector
  • PODD Health Care
  • IP Basic Materials
  • Exchange
  • PODD Nasdaq
  • IP Nasdaq
  • Market Cap
  • PODD 23.8B
  • IP 26.2B
  • IPO Year
  • PODD 2007
  • IP N/A
  • Fundamental
  • Price
  • PODD $322.22
  • IP $46.95
  • Analyst Decision
  • PODD Strong Buy
  • IP Buy
  • Analyst Count
  • PODD 18
  • IP 7
  • Target Price
  • PODD $334.50
  • IP $56.71
  • AVG Volume (30 Days)
  • PODD 568.2K
  • IP 3.6M
  • Earning Date
  • PODD 11-06-2025
  • IP 10-30-2025
  • Dividend Yield
  • PODD N/A
  • IP 3.94%
  • EPS Growth
  • PODD N/A
  • IP N/A
  • EPS
  • PODD 3.32
  • IP N/A
  • Revenue
  • PODD $2,359,500,000.00
  • IP $21,934,000,000.00
  • Revenue This Year
  • PODD $29.18
  • IP $45.40
  • Revenue Next Year
  • PODD $18.09
  • IP $4.11
  • P/E Ratio
  • PODD $96.84
  • IP N/A
  • Revenue Growth
  • PODD 26.00
  • IP 18.13
  • 52 Week Low
  • PODD $225.37
  • IP $43.27
  • 52 Week High
  • PODD $353.50
  • IP $60.36
  • Technical
  • Relative Strength Index (RSI)
  • PODD 43.19
  • IP 45.35
  • Support Level
  • PODD $336.00
  • IP $45.22
  • Resistance Level
  • PODD $351.94
  • IP $48.97
  • Average True Range (ATR)
  • PODD 10.05
  • IP 1.13
  • MACD
  • PODD -3.32
  • IP -0.14
  • Stochastic Oscillator
  • PODD 22.31
  • IP 38.25

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About IP International Paper Company

International Paper manufactures packaging products and cellulose fibers. It accounts for roughly one-third of the North American corrugated packaging market. The company also has a substantial presence in Europe following its acquisition of DS Smith. International Paper serves a variety of end markets, including industrial, consumer products, and manufacturing.

Share on Social Networks: